BNP Paribas China Equity vs UBS Lux Equity Fund Biotech USD

BNP Paribas China Equity vs UBS Lux Equity Fund Biotech USD

1. BNP Paribas China Equity

  • Security

    BNP Paribas China Equity Classic USD Cap

  • Fee

    2.23%

  • ISIN

    LU0823426308

  • Holdings

    17

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

Fund Holdings

We have information about 18 holdings in BNP Paribas China Equity, where the largest holding is Alibaba Group Holding Ltd (9.68), followed by Tencent (9.52) and Xiaomi (7.33). In comparison with UBS Lux Equity Fund Biotech USD, we have 14 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Vertex (9.9) and Moderna (9.21).

All Holdings

Here we compare the holdings in BNP Paribas China Equity and UBS Lux Equity Fund Biotech USD.

BNP Paribas China Equity UBS Lux Equity Fund Biotech USD
1. Alibaba Group Holding Ltd
China
9.68 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2. Tencent Holdings Ltd
China
9.52 %
2. Vertex Pharmaceuticals Inc
9.9 %
3. Xiaomi
China
7.33 %
3. Moderna Inc
9.21 %
4. Meituan Class B
China
5.29 %
4. Alnylam Pharmaceuticals Inc
6.54 %
5. Industrial and Commercial Bank of China Ltd Class H
China
4.58 %
5. AbbVie Inc
USA
5.52 %
6. Ping An Insurance Co
China
4.2 %
6. Gilead Sciences Inc
USA
4.66 %
7. JD.com Inc
China
3.02 %
7. Amgen Inc
4.32 %
8. NetEase ADR
China
3.01 %
8. BioNTech SE
4.13 %
9. Pinduoduo Inc
China
2.98 %
9. Karuna Therapeutics Inc
3.75 %
10. Taiwan Semiconductor Manufacturing Company
Taiwan
2.52 %
10. Royalty Pharma Plc
3.28 %
11. Pop Mart International Group Ltd
China
2.32 %
-
12. Trip.com Group Ltd
Singapore
1.96 %
-
13. KE Holdings Inc ADR
China
1.87 %
-
14. BeiGene Ltd
China
1.61 %
-
15. BYD Co Ltd Class H
China
1.59 %
-
16. Sunny Optical Technology Company Ltd
China
1.53 %
-
17. GDS Holdings Ltd ADR
China
1.22 %
-

The list of fund holdings was last updated on April 17, 2025.